ChemicalBook >> CAS DataBase List >>Tolvaptan sodium phosphate

Tolvaptan sodium phosphate

CAS No.
942619-79-6
Chemical Name:
Tolvaptan sodium phosphate
Synonyms
Tolvaptan sodiμm phosphate;Tolvaptan Sodium Phosphate;Tolvaptan Impurity(Disodium salt);Benzamide, N-[4-[[7-chloro-2,3,4,5-tetrahydro-5-(phosphonooxy)-1H-1-benzazepin-1-yl]carbonyl]-3-methylphenyl]-2-methyl-, sodium salt (1:2)
CBNumber:
CB29854079
Molecular Formula:
C26H27ClN2NaO6P
Molecular Weight:
552.92
MDL Number:
MOL File:
942619-79-6.mol
MSDS File:
SDS
Last updated:2025-05-21 16:13:46

Tolvaptan sodium phosphate Properties

FDA UNII Y4P6WS9QVF

Tolvaptan sodium phosphate price

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
ChemScene CS-0907509 Tolvaptan phosphate ester sodium 99.85% 942619-79-6 10mg $38 2026-06-04 Buy
ChemScene CS-0907509 Tolvaptan phosphate ester sodium 99.85% 942619-79-6 25mg $70 2026-06-04 Buy
ChemScene CS-0907509 Tolvaptan phosphate ester sodium 99.85% 942619-79-6 50mg $108 2026-06-04 Buy
ChemScene CS-0907509 Tolvaptan phosphate ester sodium 99.85% 942619-79-6 100mg $168 2026-06-04 Buy
aablocks AA02EOCI TOLVAPTAN PHOSPHATE SODIUM >98% 942619-79-6 10mg $74 2026-06-03 Buy
Product number Packaging Price Buy
CS-0907509 10mg $38 Buy
CS-0907509 25mg $70 Buy
CS-0907509 50mg $108 Buy
CS-0907509 100mg $168 Buy
AA02EOCI 10mg $74 Buy

Tolvaptan sodium phosphate Chemical Properties, Uses, Production

Description

Tolvaptan sodium phosphate (trade name Samtasu) is a selective small molecule vasopressin V2 receptor antagonist developed by Otsuka Pharmaceutical Co., Ltd. Tolvaptan sodium phosphate is a prodrug form of generic tolvaptan (7.13) with improved water solubility. The drug was approved by the Japanese PMDA in March 2022 for the treatment of patients with fluid retention who have difficulty taking tolvaptan orally.

Uses

Tolvaptan phosphate ester sodium, a prodrug of Tolvaptan (HY-17000), can be used in the study of cardiac edema. Tolvaptan is a selective, competitive and orally active vasopressin receptor 2 (V2R) antagonist with an IC50 of 1.28 μM for the inhibition of arginine vasopressin (AVP)-induced platelet aggregation[1][2].

Mechanism of action

Tolvaptan sodium phosphate works by inhibiting water reabsorption in the renal collecting duct, thereby enhancing water diuresis (aquaresis) without depleting electrolytes. It is effective in treating patients with heart failure and has shown clinical benefits in weight loss and reduction of dyspnea and other symptoms of fluid overload. Tolvaptan sodium phosphate is also effective in treating early acute heart failure, where water diuresis can be rapidly induced by intravenous administration of tolvaptan in the early stages.

Synthesis

The route to the precursor 7.12 of tolvaptan (7) begins with the methyl esterification of commercially available 5-chloro-2-nitrobenzoic acid 7.1 to generate an equivalent of the methyl ester 7.2. Subsequent SnCl2-mediated reduction of the nitro group affords the aminobenzoic acid 7.3, which is protected as the N-toluenesulfonamide (7.4). Alkylation of 7.4 with ethyl 4-bromobutyrate affords the intermediate 7.5, which is a precursor for intramolecular ring formation. Treatment of 7.5 with base affords the benzazepine 7.6. Global deprotection under acidic conditions affords 7.7 in good yield, accompanied by ester hydrolysis and decarboxylation. Side chain construction begins with the coupling of aniline 7.7 and acyl chloride 7.8 to afford amide 7.9. Reduction of the nitro group to aniline 7.10, followed by amidation with acyl chloride 7.11, affords intermediate 7.12 with intact side chains. Reduction of the ketone followed by phosphorylation of the free alcohol and treatment with aqueous sodium hydroxide afforded Tolvaptan sodium phosphate7.
Tolvaptan sodium phosphate
Tolvaptan sodium phosphate

References

[1] Hiroyuki Fujiki, et al. In vitro and in vivo pharmacological profile of OPC-61815, a water-soluble phosphate ester pro-drug of tolvaptan. J Pharmacol Sci. 2022 Nov;150(3):163-172. DOI:10.1016/j.jphs.2022.08.004
[2] Wu Y, et al. Mechanisms of tolvaptan-induced toxicity in HepG2 cells. Biochem Pharmacol. 2015 Jun 15;95(4):324-36. DOI:10.1016/j.bcp.2015.03.015

Tolvaptan sodium phosphate Preparation Products And Raw materials

Raw materials

Preparation Products

Tolvaptan sodium phosphate Suppliers

Global Suppliers ( 28)
Supplier Tel Email Country ProdList Advantage
XianTao Li Zhao 18571672902 1010771219@qq.com China 362 58
hongqing Huafeng Pharmaceutical Technology Co., LTD 23-67950001 13883380852 cqhfyy@foxmail.com China 74 55
Jinan Chenghui Shuangda biological Co., LTD 053158897070 15550412551 market@jnchsd.com China 224 62
CHENGHUI PHARMACEUTICAL GROUP LTD 053158897070 15550412551 market@jnchsd.com China 241 58
Shandong Chengchuang Blue Sea Pharmaceutical Technology Co., Ltd. 0531-58897130 15508676053 drug_impurity@sdcclh.com China 2526 58
TOSUN PHARM 020-66392521-118 18922260391 3004261881@qq.com China 7994 58
Dideu Industries Group Limited +8617392712697 1022@dideu.com China 29091 58
Jinan chenghui-shuangda chemical co.,ltd. 13256107535 mahaiyan1123@126.com China 118 58
NANJING WEDO PHARMATECH CO.,LTD. 15189836218 wedo-chem@huawe.com China 240 58
PureChemland Co.,Ltd. 13540909846 13882008651 3848291069@qq.com China 3000 58

View Latest Price from Tolvaptan sodium phosphate manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
Tolvaptan Sodium Phosphate pictures 2025-12-25 Tolvaptan Sodium Phosphate
942619-79-6
1g 0.99 50kg Wuhan Biocar Pharmacy CO.,Ltd.
Benzamide, N-[4-[[7-chloro-2,3,4,5-tetrahydro-5-(phosphonooxy)-1H-1-benzazepin-1-yl]carbonyl]-3-methylphenyl]-2-methyl-, sodium salt (1:2) Tolvaptan Impurity(Disodium salt) Tolvaptan Sodium Phosphate Tolvaptan sodiμm phosphate 942619-79-6 C26H27ClN2NaO6P API